EUVIMEDOpdag EUVIMED
Open access

Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users

Nerissa Nance iD, Sylvia E Badon iD, Kathryn Ridout iD, Jennifer Ahern, De-Kun Li iD, Charles Quesenberry, Lyndsay A Avalos iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023

DOI: 10.1002/phar.2790 ↗

At a glance

Journal article in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023. Written by Nerissa Nance and 6 co-authors. Institution: Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. Major MEDLINE topics: Premature Birth, Pregnancy Complications. Cited 3 times so far (Crossref); 46 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, Kaiser Permanente, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Little is known about antidepressant medication use patterns during pregnancy among periconception (before and immediately following conception) users. Additionally, the associations between these patterns and birth outcomes is unclear, after taking into account underlying depression severity.

Objective

This study describes patterns of antidepressant use among periconception users and examines associations between usage patterns and birth outcomes. Study Design This retrospective cohort study included pregnant Kaiser Permanente Northern California (KPNC) members with a live birth between 2014 and 2017 and an antidepressant medication fill that overlapped the 8th week of pregnancy. Outcomes were preterm birth and neonatal intensive care unit (NICU) admission. Data were extracted from KPNC's electronic health records. Modified Poisson regression was conducted.

Results

Of the 3637 pregnancies meeting inclusion criteria, 33% ( n = 1204) continued antidepressant use throughout the pregnancy (refilled throughout pregnancy), 47% ( n = 1721) discontinued use (no refills), and 20% ( n = 712) stopped and reinitiated use (refill after 30+ day gap in supply). Women who continued use had 1.86 (95% confidence interval (CI) 1.53, 2.27) times the risk of preterm birth and 1.76 (95% CI: 1.42, 2.19) times the risk of NICU admission, compared to women who discontinued use during pregnancy. Similarly, women with continued use had 1.66 (95% CI: 1.27, 2.18) times the risk of preterm birth and 1.85 (95% CI: 1.39, 2.46) times the risk of NICU admission, compared to women who stopped and reinitiated use. This relationship held when examining continuous exposure; the relationship between continuous exposure and preterm delivery was stronger in later trimesters.

Conclusions

Periconception antidepressant users who continue use during pregnancy, particularly into the second and third trimesters, may be at higher risk of adverse birth outcomes. This evidence should be considered alongside the risks associated with depression relapse.

Subjects

MeSH terms (MEDLINE)

Premature BirthPregnancy ComplicationsPregnancyInfant, NewbornFemaleHumansRetrospective StudiesAntidepressive Agents

Author keywords

antidepressant medicationanxietymood disordersperinatal depressionpregnancy

Substances

Antidepressive Agents

Authors and institutions

  • Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • University of California, Berkeley, Berkeley, California, USA.
  • The Permanente Medical Group, Oakland, California, USA.

ORCID profiles: Nerissa Nance, Sylvia E Badon, Kathryn Ridout, De-Kun Li, Lyndsay A Avalos

Funding

  • NICHD NIH HHS
  • Kaiser Permanente
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Cite

APA

Nance, N., Badon, S. E., Ridout, K., Ahern, J., Li, D. K., Quesenberry, C., & Avalos, L. A. (2023). Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2790

Vancouver

Nance N, Badon SE, Ridout K, Ahern J, Li DK, Quesenberry C, et al. Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023. doi:10.1002/phar.2790

BibTeX
@article{Nance2023,
  author = {Nance, Nerissa and Badon, Sylvia E and Ridout, Kathryn and Ahern, Jennifer and Li, De-Kun and Quesenberry, Charles and Avalos, Lyndsay A},
  title = {Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2023},
  doi = {10.1002/phar.2790}
}
Start for free →